Trial Profile
The effect of rimonabant treatment on cardiovascular risk factors in renal transplant recipients -- pilot safety study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2014
Price :
$35
*
At a glance
- Drugs Rimonabant (Primary) ; Ciclosporin; Tacrolimus
- Indications Cardiovascular disorders; Obesity; Renal transplant rejection
- Focus Pharmacokinetics
- Acronyms RIMONA-PILOT
- 09 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Sep 2007 New trial record.